0001607062-19-000359.txt : 20190911 0001607062-19-000359.hdr.sgml : 20190911 20190911154559 ACCESSION NUMBER: 0001607062-19-000359 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190627 FILED AS OF DATE: 20190911 DATE AS OF CHANGE: 20190911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Prioletti Mark Joseph SE CENTRAL INDEX KEY: 0001786759 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 191088252 MAIL ADDRESS: STREET 1: 1121 PALMER COURT CITY: CRYSTAL LAKE STATE: IL ZIP: 60014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 416-364-2551 MAIL ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 3 1 ownership.xml X0206 3 2019-06-27 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001786759 Prioletti Mark Joseph SE 1121 PALMER COURT CRYSTAL LAKE IL 60014 1 0 0 0 Common Voting Shares 3568 D /s/ Mark Prioletti 2019-06-27